$BDX

Nephros, Inc. reported its Q4 2025 earnings with a notable increase in revenue driven by their innovative filtration technologies and a strengthened demand in the healthcare sector. The company also provided optimistic guidance for the upcoming fiscal year, projecting continued growth and expansion into new markets. Despite facing some operational challenges, Nephros plans to invest in research and development to enhance its product offerings. Investor sentiment appears largely positive following the earnings call, reflecting confidence in the company's strategic direction. Overall, the outlook suggests Nephros is well-positioned to capitalize on industry trends moving forward.